Zoetis stockZTS
Zoetis trades at $82.11, 37.8% below its 52-week high (Feb 12, 2026). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −34.2% year to date, −31.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
- Market pulseZoetis beats Q3 estimates with adjusted EPS $1.75, revenue $2.39B, raises 2026 EPS outlook and narrows revenue guidance
- Market pulseZoetis raises 2026 EPS guidance and narrows revenue outlook amid persistent companion animal headwinds
- BenzingaNeogen Says Australian, New Zealand Review Of Genomics Sale To Zoetis Expected To Conclude Early 2027; Zoetis Offered To Divest Some Australian Assets
The trigger was the quarterly report: EPS +3% year over year, 15.7% above the estimate.
All moves of the day →Ratings, candles, signals and the screener for ZTS — after you log in
Open the terminalFrequently asked questions about Zoetis
What is the Zoetis stock price?
At the close on Nov 5, 2026: $82.11 (−7.95% on the day). 52-week high: $131.92 on Feb 12, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Zoetis report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +3% year over year, revenue 0%.
Does Zoetis pay dividends?
Yes, the dividend yield is about 2.66% a year.
Where does Zoetis trade and how to buy it?
Ticker ZTS, exchange NYSE, listed since 2013. You can buy it through a broker with access to US exchanges.
Should I buy Zoetis now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ZTS are in the terminal after you log in.